Triple-positive profile may flag adverse prostate cancer pathology - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Triple-positive profile may flag adverse prostate cancer pathology

A combination of PSA density, MRI, and PSMA PET findings identified a small subgroup with adverse pathology, supporting further study of biopsy-sparing pathways.

  • By

  • Andrea Surnit

  • September 8, 2026

  • 4 min

Share

  • 1

    A combination of prostate-specific antigen density, mpMRI, and PSMA PET/CT may identify patients with adverse prostate cancer pathology.

  • 2

    In a study of 413 patients, 60% exhibited adverse pathology at radical prostatectomy.

  • 3

    The triple-positive profile showed 100% specificity and positive predictive value, but low sensitivity at 9%.

  • 4

    The study suggests this profile could guide future studies on biopsy-sparing diagnostic pathways.

  • 5

    The findings highlight the need for external validation before adopting these criteria in prospective studies.

Original Source(s)

Triple-positive profile may flag adverse prostate cancer pathology

  • by Andrea Surnit

  • September 8, 2026

Related Content

AI cuts lesion measurement time by 34%

Automated lesion measurements increased agreement on treatment response, although expert-generated proposals were accepted more often and required fewer adjustments.

Second Primary Cancer Risk Shifts Over Time

US registry study finds overall declines but rising risk in lung, melanoma, and older survivor groups

Reduced-Dose Radiation Shows Durable Control

Single-arm cohort findings contrast with interim results from NRG-HN005, underscoring ongoing uncertainty around treatment deintensification.